1
00:00:02,520 --> 00:00:09,960
Speaker 1: Bloomberg Audio Studios, podcasts, radio news. The Stock Movers report,

2
00:00:10,280 --> 00:00:13,520
Speaker 1: your roundup of companies making moves in the stock market

3
00:00:13,680 --> 00:00:15,880
Speaker 1: harnessing the power of Bloomberg Data.

4
00:00:16,800 --> 00:00:18,560
Speaker 2: Let's take a look now at some of the individual

5
00:00:18,640 --> 00:00:21,800
Speaker 2: stocks on the move today. I'm Paul Sweeney alongside lismithte

6
00:00:21,880 --> 00:00:24,759
Speaker 2: and we're joined by Bloomberg's Tatiana Darier. Jenny. What are

7
00:00:24,760 --> 00:00:25,400
Speaker 2: you looking at today?

8
00:00:25,680 --> 00:00:28,560
Speaker 3: Well, Paul got to look a palanteer again. Up here

9
00:00:28,680 --> 00:00:31,400
Speaker 3: eight percent, the second largest mover in this MP five

10
00:00:31,480 --> 00:00:34,640
Speaker 3: hundred right now after reporting a forty eight percent surge

11
00:00:34,720 --> 00:00:39,360
Speaker 3: in revenue, and it was growth across segments revenue from government.

12
00:00:39,960 --> 00:00:44,159
Speaker 3: The government segment climbed fifty three percent above estimates. And

13
00:00:44,240 --> 00:00:48,080
Speaker 3: what analysts are most excited about, though, are the is

14
00:00:48,120 --> 00:00:52,560
Speaker 3: the commercial segment and growth there. That revenue has grown

15
00:00:52,600 --> 00:00:55,720
Speaker 3: by about ninety three percent for the year, and to

16
00:00:56,200 --> 00:00:59,440
Speaker 3: in analyst views, this is a key indicator of robust

17
00:00:59,440 --> 00:01:03,760
Speaker 3: demand for their AI systems. The stock here up eight percent,

18
00:01:04,000 --> 00:01:07,880
Speaker 3: up more than what now, one hundred and twenty percent.

19
00:01:07,959 --> 00:01:12,320
Speaker 3: Here today the fifth largest contributor to SMP five hundred gains,

20
00:01:12,360 --> 00:01:15,160
Speaker 3: So it's no longer just a retail favorite. This has

21
00:01:15,200 --> 00:01:18,360
Speaker 3: become a bigger force for the SMP five hundred as

22
00:01:18,360 --> 00:01:18,679
Speaker 3: a whole.

23
00:01:18,760 --> 00:01:20,760
Speaker 4: Well, yeah, especially with all their government contracts that you

24
00:01:20,800 --> 00:01:23,560
Speaker 4: were talking about, too huge for them. Okay, let's move

25
00:01:23,640 --> 00:01:25,680
Speaker 4: on to a Caterpillar because a lot of people look

26
00:01:25,680 --> 00:01:27,080
Speaker 4: at this. It's kind of like this bell weather for

27
00:01:27,120 --> 00:01:27,640
Speaker 4: the economy.

28
00:01:27,840 --> 00:01:32,440
Speaker 3: Exactly, a big macro name shares are pairing drop their

29
00:01:32,520 --> 00:01:35,160
Speaker 3: drop now they're about flat or slightly lowered by three

30
00:01:35,200 --> 00:01:38,720
Speaker 3: tenths of a percent, and miss Onypus results are tariffs

31
00:01:38,760 --> 00:01:43,040
Speaker 3: are biding into profitability. The company projected a net impact

32
00:01:43,120 --> 00:01:47,040
Speaker 3: from incremental tariffs of over a billion, somewhere between one

33
00:01:47,080 --> 00:01:50,680
Speaker 3: point three to one point five. Baired estimates that levees

34
00:01:50,760 --> 00:01:53,960
Speaker 3: are now dragging margins by about two hundred to three

35
00:01:54,040 --> 00:01:57,480
Speaker 3: hundred basis points. So that's why their guidance is coming

36
00:01:57,480 --> 00:02:00,000
Speaker 3: at the low end of their guidance of four margins

37
00:02:00,000 --> 00:02:04,720
Speaker 3: and even though they're projecting growth in their annual sales.

38
00:02:04,720 --> 00:02:06,960
Speaker 3: So that's kind of an interesting because it sort of

39
00:02:07,240 --> 00:02:10,760
Speaker 3: goes against what we've seen with the industrials, where analysts

40
00:02:10,800 --> 00:02:13,680
Speaker 3: are saying that they do retain some of the pricing power,

41
00:02:13,840 --> 00:02:16,480
Speaker 3: where for Caterpillar it doesn't appear to be the case.

42
00:02:16,600 --> 00:02:18,840
Speaker 2: Yeah, it's interesting. You would think if somebody would have

43
00:02:18,919 --> 00:02:21,480
Speaker 2: some pricing power would be somebody with a brand name

44
00:02:21,560 --> 00:02:24,760
Speaker 2: as strong as Caterpillar and a global name. But it's

45
00:02:24,840 --> 00:02:29,520
Speaker 2: impacting all types of companies here, hymns and hers, hims

46
00:02:29,600 --> 00:02:30,120
Speaker 2: and hers.

47
00:02:30,160 --> 00:02:34,200
Speaker 3: Interesting name saw a total reversal here over the past hour.

48
00:02:34,280 --> 00:02:36,520
Speaker 3: You know, it was down about fourteen percent. The pre

49
00:02:36,600 --> 00:02:41,120
Speaker 3: market now is about flat. Analysts and investors are reconsidering

50
00:02:41,520 --> 00:02:44,800
Speaker 3: their results. It posted a second quarter revenue miss and

51
00:02:45,160 --> 00:02:50,080
Speaker 3: sort of the weakness stems from their weight loss drug sales.

52
00:02:50,280 --> 00:02:52,760
Speaker 3: And you know, the story here is that this talk

53
00:02:52,800 --> 00:02:55,200
Speaker 3: has risen a lot more than one hundred and sixty

54
00:02:55,240 --> 00:02:59,280
Speaker 3: percent this year because they've been selling copycat versions of

55
00:02:59,320 --> 00:03:03,280
Speaker 3: the popular weight loss drugs from ili Le Novo Nordisk. Now,

56
00:03:03,320 --> 00:03:06,160
Speaker 3: the FDA came out earlier this year and said stop

57
00:03:06,280 --> 00:03:08,520
Speaker 3: selling copycats. We don't want them on the market.

58
00:03:08,680 --> 00:03:11,040
Speaker 2: I've never understood why they. I guess they allowed it

59
00:03:11,080 --> 00:03:15,040
Speaker 2: because the Zempics of the world were in a short supply,

60
00:03:15,520 --> 00:03:18,960
Speaker 2: so they allowed kind of these knockoffs to kind of

61
00:03:19,000 --> 00:03:20,839
Speaker 2: go to the market. Is that kind of what happened.

62
00:03:20,800 --> 00:03:24,600
Speaker 3: Exactly, Paul, They're they're in high demand everywhere, even abroad.

63
00:03:25,440 --> 00:03:29,360
Speaker 3: And now Jeffrey is saying that perhaps investors are overlooking

64
00:03:29,400 --> 00:03:32,440
Speaker 3: other positives in the numbers, like the second quarter even

65
00:03:32,480 --> 00:03:35,120
Speaker 3: a bit and the fact that they're going to launch

66
00:03:35,160 --> 00:03:39,280
Speaker 3: a hormonal health sort of are pivoting away from weight

67
00:03:39,360 --> 00:03:44,160
Speaker 3: loss to hormonal therapies and expanding into other places like Canada.

68
00:03:44,240 --> 00:03:46,480
Speaker 3: But I feel like my theory is that it just

69
00:03:46,560 --> 00:03:49,840
Speaker 3: goes up or palenteer here lifting all boats, you know,

70
00:03:50,160 --> 00:03:52,760
Speaker 3: weight loss, AI, all popular things.

71
00:03:53,960 --> 00:03:55,800
Speaker 4: Well, it's funny because they had that partnership with Novo

72
00:03:55,960 --> 00:03:58,000
Speaker 4: Nordis for a week, go v at the discount, and

73
00:03:58,040 --> 00:04:01,040
Speaker 4: then that just didn't work out very well for them.

74
00:04:01,280 --> 00:04:05,800
Speaker 3: No, not at all with the Novo Nordics. They're accusing

75
00:04:05,840 --> 00:04:09,000
Speaker 3: them of illegal mass compounding and quote, this is.

76
00:04:09,200 --> 00:04:13,040
Speaker 2: The best compounding, So these aren't. They're not trying to

77
00:04:13,040 --> 00:04:17,280
Speaker 2: think they're not knockoffs. Their compounds I think is the term.

78
00:04:17,520 --> 00:04:20,360
Speaker 2: And they kind of get you very very very close

79
00:04:20,400 --> 00:04:21,760
Speaker 2: to the original drope but.

80
00:04:21,720 --> 00:04:22,520
Speaker 4: Not all there.

81
00:04:22,600 --> 00:04:25,400
Speaker 3: Yeah, and price is key, right, it's more affordable in

82
00:04:25,480 --> 00:04:30,520
Speaker 3: a more accessible for people. Well, the next name here

83
00:04:30,640 --> 00:04:34,240
Speaker 3: in the health care space is a Vertex down about

84
00:04:34,520 --> 00:04:40,280
Speaker 3: seventeen percent. It has expanded extended losses here from the

85
00:04:40,320 --> 00:04:43,240
Speaker 3: pre market. The story there is that the FDA came

86
00:04:43,240 --> 00:04:47,919
Speaker 3: out and said that one of their paint pills doesn't

87
00:04:47,960 --> 00:04:50,680
Speaker 3: have or it doesn't see a path teacher for a

88
00:04:50,760 --> 00:04:54,200
Speaker 3: broad use in treating a certain type of chronic pain.

89
00:04:54,720 --> 00:04:56,560
Speaker 3: This is a big one for them because they've been

90
00:04:56,600 --> 00:04:59,719
Speaker 3: trying to pivot their business away from a systic fibrosis

91
00:04:59,800 --> 00:05:02,680
Speaker 3: and this is the first type of pinkiller to reach

92
00:05:02,760 --> 00:05:05,120
Speaker 3: the US market in more than two decades, so it's

93
00:05:05,120 --> 00:05:07,800
Speaker 3: a big one for them. They're studying it in various

94
00:05:07,800 --> 00:05:12,840
Speaker 3: different uses well for this particular use for chronic pain

95
00:05:13,000 --> 00:05:16,440
Speaker 3: costs for nerve damage. The FDA is saying that it

96
00:05:16,480 --> 00:05:18,960
Speaker 3: doesn't see a back forward, and that is knocking the

97
00:05:19,000 --> 00:05:24,040
Speaker 3: stock off here down seventeen percent. Ear Tickers vrtns.

98
00:05:23,880 --> 00:05:27,920
Speaker 1: The Stock Movers Report from Bloomberg Radio. Check back with

99
00:05:28,000 --> 00:05:30,599
Speaker 1: us throughout the day for the latest roundup of companies

100
00:05:30,640 --> 00:05:33,760
Speaker 1: making news on Wall Street and for the latest market

101
00:05:33,760 --> 00:05:38,240
Speaker 1: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,

102
00:05:38,360 --> 00:05:41,839
Speaker 1: Bloomberg dot com, and on Applecarplay and Android Auto with

103
00:05:41,920 --> 00:05:43,400
Speaker 1: the Bloomberg Business app.